Is insulin resistance atherogenic? A review of the evidence

被引:18
作者
Ferrannini, Ele [1 ]
Iozzo, Patricia [1 ]
机构
[1] Dept Internal Med, I-56126 Pisa, Italy
关键词
antherogenic; cardiovascular disease; insulin resistance;
D O I
10.1016/j.atherosclerosissup.2006.05.006
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several factors that increase the risk of cardiovascular disease tend to cluster together in the same individual. Insulin resistance is believed to be a pathophysiological disturbance that underlies many of the risk factors. Whether insulin resistance per se is a cardiovascular risk factor is uncertain. Insulin resistance of myocardial muscle has been documented both in patients with type 2 diabetes and in nondiabetic subjects with angiographically proven coronary artery disease. In addition, in diabetic patients there is a mismatch between the redistribution of blood flow and glucose uptake during insulinization. Finally, the endothelial dysfunction and the hyperinsulinemia that accompany insulin resistance may adversely affect myocardial function. The evidence from epidemiological studies or clinical trials is, however, mixed. In at least one recent prospective study in patients with congestive heart failure, insulin resistance was an independent predictor of cardiac death. Conclusive proof would require a prospective study in which insulin resistance is measured directly and adequate account is taken of the classical cardiovascular risk factors. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 25 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study [J].
Arad, Y ;
Newstein, D ;
Cadet, F ;
Roth, M ;
Guerci, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :2051-2058
[4]   Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2003, 26 (04) :1251-1257
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss [J].
Emdin, M ;
Gastaldelli, A ;
Muscelli, E ;
Macerata, A ;
Natali, A ;
Camastra, S ;
Ferrannini, E .
CIRCULATION, 2001, 103 (04) :513-519
[7]   METABOLIC AND HEMODYNAMIC-EFFECTS OF INSULIN ON HUMAN HEARTS [J].
FERRANNINI, E ;
SANTORO, D ;
BONADONNA, R ;
NATALI, A ;
PARODI, O ;
CAMICI, PG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :E308-E315
[8]   Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis - The Atherosclerosis Risk in Communities Study [J].
Golden, SH ;
Folsom, AR ;
Coresh, J ;
Sharrett, AR ;
Szklo, M ;
Brancati, F .
DIABETES, 2002, 51 (10) :3069-3076
[9]   Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease - The San Antonio Heart Study [J].
Hanley, AJG ;
Williams, K ;
Stern, MP ;
Haffner, SM .
DIABETES CARE, 2002, 25 (07) :1177-1184
[10]   The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives [J].
Hills, SA ;
Balkau, B ;
Coppack, SW ;
Dekker, JM ;
Mari, A ;
Natali, A ;
Walker, M ;
Ferrannini, E .
DIABETOLOGIA, 2004, 47 (03) :566-570